Navigation Links
Low-carb diets alter glucose formation by the liver
Date:10/20/2008

stable group, who consumed carbohydrates as a significant proportion of their diet, the TCA cycle alone provided sufficient energy to drive glucose formation. "This was not the case in individuals undergoing carbohydrate restriction," the authors report.

Carbohydrate restriction increased the rate of glucose formed using lactate or amino acids (GNGpep). "This suggests that in fasted human subjects undergoing weight loss, the elevated gluconeogenesis associated with carbohydrate restriction is driven by substrates such as lactate or amino acids," the authors report. In spite of this, TCA cycle flux in the low-carbohydrate group was similar to the low-calorie group, indicating similar rates of energy generation.

In contrast to previous reports, the present study showed similar hepatic glucose production among the dietary groups. The low-carbohydrate group was able to maintain hepatic glucose production at the levels observed for the weight-stable and low-calorie groups by increasing glucose formation using lactate or amino acids to match the reduction in glucose formation from glycerol.

"This observation is reminiscent of 'hepatic autoregulation' by which endogenous glucose production remains unchanged in the setting of altered gluconeogenesis or glycogenolysis because the two pathways tend to compensate for each other," the authors report.

They noted it was interesting that the increased glucose formation using lactate or amino acids in the low-carbohydrate group was not associated with increased TCA cycle flux (i.e. energy production.) However, they did not measure absolute rates of fatty acid delivery to the liver or ketone body production, limiting their ability to further interpret that finding.

"We have shown that the sources from which endogenous glucose is produced are dependent upon dietary macronutrient composition," the authors write. They suggest that the shift in glucose metabolism associated with a low carb
'/>"/>

Contact: Sean Wagner
swagner@wiley.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Low-Carb Diets Better Than Low-Fat Diets at Preventing Diabetes
2. Diabetes Group Backs Low-Carb Diets
3. Low-carb diet reduces inflammation and blood saturated fat in metabolic syndrome
4. Low-Carb Diet May Slow Prostate Tumor Growth
5. A low-carb diet may stunt prostate tumor growth
6. Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss No Diet, No Stuff Method. Hates Diets, Loves to Have People Help Themselves
7. eDiets.com(R) Announces Q2 2008 Results
8. Whos Who Weight Specialist Martin Schiff, M.D., 86, Devoting Rest of Life to Spreading Truth About Diets, Wont Accept Compensation From Anyone, Sending Complete Guide Free to All
9. NEJM: Low-fat diets not best for weight loss: New study by Ben-Gurion U. of the Negev
10. Survey Indicates Lifestyle Change Is More Important Than Diets
11. eDiets.com(R) Appoints New Chief Information Officer Laura Klein
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 2Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 2Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 4Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 2Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 3Health News:Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts 2Health News:Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts 3Health News:Coffee, Exercise Fight Prostate Cancer 2Health News:Coffee, Exercise Fight Prostate Cancer 3
Other Medicine News:Health News:China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores 2Health News:China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores 3Health News:China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores 4Health News:University Hospitals in Cleveland Selects Solution Suite from Agilysys 2Health News:University Hospitals in Cleveland Selects Solution Suite from Agilysys 3Health News:University Hospitals in Cleveland Selects Solution Suite from Agilysys 4Health News:CSC Survey Reveals Hospitals Find Current Recession Far Worse Than Last Downturn; Emergency Visits to Climb 2Health News:CSC Survey Reveals Hospitals Find Current Recession Far Worse Than Last Downturn; Emergency Visits to Climb 3Health News:Haemacure's Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury 2Health News:Haemacure's Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury 3Health News:Senior Housing and Services Provider Ecumen Welcomes Jim Klobuchar to Its Changing Aging Blog 2Health News:Senior Housing and Services Provider Ecumen Welcomes Jim Klobuchar to Its Changing Aging Blog 3Health News:Natural Healers Researches Natural Health Careers to Make the Prospective Holistic Health Students' Job Easier 2Health News:Natural Healers Researches Natural Health Careers to Make the Prospective Holistic Health Students' Job Easier 3
Breaking Medicine Technology:Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4AstraZeneca Medicare Part D Patient Assistance Program No Longer Requires Co-Pays 2First Time Father to Be Quits Smoking Wins 245 000 in The QuitCash Challenge 28TM 29 61753 1First Time Father to Be Quits Smoking Wins 245 000 in The QuitCash Challenge 28TM 29 61753 2First Time Father to Be Quits Smoking Wins 245 000 in The QuitCash Challenge 28TM 29 61753 3Teamsters Oppose Senate Plan to Tax Health Insurance Companies 61750 1Monogram Energy Inc Acquires Triad Therapeutics Inc 61747 1Monogram Energy Inc Acquires Triad Therapeutics Inc 61747 2